圣杯
血糖性
胰岛素
医学
加药
糖尿病
2型糖尿病
重症监护医学
内分泌学
内科学
计算机科学
万维网
作者
Jinpeng Han,Zhen Gu,Jicheng Yu
出处
期刊:Matter
[Elsevier]
日期:2021-12-01
卷期号:4 (12): 3790-3791
被引量:4
标识
DOI:10.1016/j.matt.2021.10.030
摘要
Oral insulin therapy is always viewed as the holy grail of diabetes management. In this issue of Matter, Tao and colleagues developed a glucose-responsive oral insulin nanoplatform to achieve effective glycemic control and reduce the dosing frequency to once a day in type 1 diabetic mice.
科研通智能强力驱动
Strongly Powered by AbleSci AI